Although there was a weak trend for “Under 25, CD4<200” to reduce time-discounted AIDS deaths relative to “Under age 25” for Starg between 50 and 60% using a 7% discount rate, CD4-age hybrids did not reduce time-discounted AIDS deaths using the standard 3% discount rate (S9 Fig). This evidence concerns the gene CD4 and AIDS.